Jeff Hall

The AI-powered software NeuroQuant PET reportedly offers automated quantification and structured reporting and facilitates evaluation of brain scans with multiple amyloid PET radiotracers.

Preliminary research with the PET radiopharmaceutical 68Ga-NYM096 has demonstrated a 95.7 percent accuracy rate in patients with primary clear cell renal cell carcinoma (ccRCC) and a significantly higher mean SUVmax in the most active lesions in comparison to 18F-FDG.

For patients who had successful reperfusion after acute ischemic stroke, new research demonstrated an 80 percent AUC for predicting infarct with the combination of apparent diffusion coefficient (ADC) mapping and relative oxygen ejection fraction (rOEF).

The cmAngio 2.0 AI-enabled software reportedly offers new capabilities for quantitative measurement of breast arterial calcification (BAC) as well as age-based contextualization based on mammography assessment.

New research revealed that risk-stratified MRI surveillance in patients with cirrhosis led to over a 10 percent increase in early detection and over a 44 percent decrease in surveillance exams in comparison to reported results with semiannual ultrasound monitoring.

Catch up on the latest contrast-enhanced mammography research, CT insights, MRI studies and FDA approvals in PET imaging with our Weekly Scan.

Recent positron emission tomography (PET) studies with florquinitau F 18 injection (Tauklarify) demonstrated inter-reader agreement ranging between 86 to 92 percent in evaluating patients for Alzheimer’s disease.

Use of the CARE Multi-Triage CT Body software will be eligible for a New Technology Add-on Payment (NTAP) from CMS starting on October 1, 2026 for inpatients in Medicare fee for service plans.

In a recent episode of our “Molecular Imaging in Focus” series, Martin Pomper, MD, PhD, discussed the origin of PSMA PET, shared his perspective on non-PSMA targets in prostate cancer and offered his thoughts on the potential promise of emerging theranostics.

The VueJect ultrasound contrast delivery system, which is geared toward cardiac ultrasound imaging, also gained Health Canada authorization.

In comparison to standard readout-segmented echo-planar imaging, the combination of deep learning reconstruction and multi-shot diffusion-weighted imaging (DWI) offered significantly higher SNR, CNR and lesion contrast with a greater than a two-minute reduction in scan time.

Noting the rising imaging volume and dearth of MRI scanner availability, the authors of a new literature review explore the utility and impact of workflow redesign, staff training, scheduling improvements and AI advances for enhancing MRI workflows.

In a recently published review of the BI-RADS v2025 manual, leading breast radiologists offered pertinent insights on key changes for reporting of mammogram, breast ultrasound and breast MRI interpretation and assessment.

In a recent interview, Kay Jann, PhD, discussed challenges with urinary continence in stroke survivors and a forthcoming NIH-funded study examining the use of brain MRI to help identify those who may benefit from transcutaneous spinal cord stimulation (TSCS).

In comparison to 2023 statistics, the authors of a new study noted an approximately 49 percent increase in radiology turnaround time for ultrasound interpretation and over a 35 percent increase in turnaround time for X-ray assessments.

Extracellular volume fraction (ECV) assessment with photon-counting CT offered higher sensitivity and comparable specificity and AUC to magnetic resonance elastography (MRE)-derived liver stiffness measurement (LSM) for evaluating patients with stage 2 or higher fibrosis, according to a recent study.

The AI tools for the newly launched Invenia ABUS Prime ultrasound platform reportedly facilitate a 40 percent increase in scan speed and up to a 93 percent sensitivity rate for lesion detection in women with dense breasts.

Catch up on the top radiology content of the past week.

Based on results from the phase III PSMAddition trial, the expanded approval may nearly double the number of patients with prostate cancer who can be treated with Pluvicto.

Combining automated lesion detection and characterization, the DeepHealth Breast Ultrasound software reportedly offers greater than 98 percent sensitivity for localizing breast lesions and reduces interpretation time for radiologists by 37 percent.

Offering rapid loading and viewing access for CT, MRI, ultrasound, PET imaging and mammograms, the ImageGrid® StreamVue platform can be integrated into existing PACS environments at hospitals and imaging centers.

Utilization of the ThinkSono Guidance software app by non-ultrasound trained clinicians on point-of-care ultrasound devices reportedly facilitated diagnostic image quality in 87.1 percent of cases, according to recent research.

Recently presented research with the AI-powered CaRi-Heart software at the Society of Cardiovascular Computed Tomography (SCCT) conference found that assessments of advanced coronary inflammation with the software were linked to significantly higher cardiovascular mortality risks.

In comparison to findings from a similar study in 2014, the national volume computed tomography (CT) dose index (CTDLvol) declined by 9.3 percent, according to newly published research involving 5 million CT exams for over 2.8 million adults in 2025.

In an external test set from a recent study, a combined radiomic/deep learning model for intratumoral computed tomography (CT) threshold segmentation offered an 82.3 percent AUC and 95.4 percent sensitivity for predicting visceral pleural invasion in patients with lung adenocarcinoma < 30 mm.

For biopsy-naïve patients who had radical prostatectomy for prostate cancer, new research suggests that biparametric MRI is comparable to multiparametric MRI for detecting extraprostatic extension.

Catch up on the top radiology content of the past week.

In a recent interview, Kenneth Chan, MBBS, discussed new research, presented at the recent Society of Cardiovascular Computed Tomography (SCCT) conference, that showed the impact of coronary inflammation in identifying elevated cardiovascular risk in patients with zero or low coronary artery calcium (CAC) scores.

The HOPPR EF Chest CT Narrative Model reportedly provides narrative language describing pertinent findings across pulmonary, upper abdominal, cardiac, mediastinal and soft tissue regions with processing of 3D chest CT volumes.

A model combining MRI and ultrasound findings yielded a 93 percent AUC for predicting microvascular invasion in hepatocellular carcinoma.